Shares of Insulet (NASDAQ: PODD), a medical device company, are jumping in response to regulatory approval of a new product. Investors excited about the company's new automated insulin delivery system pushed the stock 15% higher as of 11:57 a.m. ET on Friday. Today the company announced the FDA has finally approved OmniPod 5 after several long delays.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting